Latest filing published 20 Aug 2024 for Oncology Institute, Inc..
Filing timeline
BuySaleInsider track record
Havencrest Healthcare Partners, L.P.: trading record in brief
This profile gathers the share dealings of Havencrest Healthcare Partners, L.P. in Starling Oncology, Inc. We count 72 filings; the first trade dates from 12 August 2022 and the latest from 16 August 2024.
On the market, this insider has only sold: 68 sales, €10.5M in total. 2024 to date brings no purchases and 7 sales.
The latest filing, published on 20 August 2024, reports a transaction in Starling Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Havencrest Healthcare Partners, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,701,823 shares0Common stockSEC:0000950170-24-098843:0
- 8,637 shares@ US$2.120.5% of flowCommon stockSEC:0000950170-24-009050:0
- 24,915 shares@ US$2.301.4% of flowCommon stockSEC:0000899243-24-000121:0
- 11,986 shares@ US$2.130.6% of flowCommon stockSEC:0000899243-24-000108:0
- 4,561,050 shares0Common stockSEC:0000950170-24-000345:0
- 365,321 shares@ US$2.3322.5% of flowCommon stockSEC:0000899243-22-035946:0
- 27,000 shares@ US$3.242.4% of flowCommon stockSEC:0000899243-22-035588:0
- 45,500 shares@ US$3.584.5% of flowCommon stockSEC:0000899243-22-035320:0
- 41,855 shares@ US$4.695.3% of flowCommon stockSEC:0000899243-22-034844:0
- 52,500 shares@ US$5.167.2% of flowCommon stockSEC:0000899243-22-034501:0
- 20,000 shares@ US$4.962.7% of flowCommon stockSEC:0000899243-22-034156:0
- 12,200 shares@ US$4.631.5% of flowCommon stockSEC:0000899243-22-033908:0
- 25,200 shares@ US$4.673.2% of flowCommon stockSEC:0000899243-22-033713:0
- 21,500 shares@ US$4.332.6% of flowCommon stockSEC:0000899243-22-033524:0
- 14,060 shares@ US$4.781.8% of flowCommon stockSEC:0000899243-22-033327:0
- 11,000 shares@ US$4.681.4% of flowCommon stockSEC:0000899243-22-032851:0
- 14,074 shares@ US$4.691.9% of flowCommon stockSEC:0000899243-22-032266:0
- 13,086 shares@ US$4.251.5% of flowCommon stockSEC:0000899243-22-032050:0
- 68,500 shares@ US$4.558.4% of flowCommon stockSEC:0000899243-22-031553:0
- 38,000 shares@ US$5.525.6% of flowCommon stockSEC:0000899243-22-031089:0
- 45,000 shares@ US$6.047.3% of flowCommon stockSEC:0000899243-22-030763:0
- 31,500 shares@ US$6.165.2% of flowCommon stockSEC:0000899243-22-030551:0
- 15,000 shares@ US$6.142.5% of flowCommon stockSEC:0000899243-22-030146:0
- 21,084 shares@ US$6.373.6% of flowCommon stockSEC:0000899243-22-029900:0
- 10,873 shares@ US$6.812.0% of flowCommon stockSEC:0000899243-22-029569:0
25 of 26 declarations
